Advertisement
Advertisement
OGN
Organon & Co.
6.05
USDSponsored
-0.05
-0.75%
Mar 26, 15:59 UTC -4
Closed
After-Market
6.13
+0.08
+1.32%
OGN Earnings Reports
Positive Surprise Ratio
OGN beat 15 of 20 last estimates.
75%
Next Report
Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.51B
/$0.83
Implied change from Q4 25 (Revenue/ EPS)
+0.42%
/+31.75%
Implied change from Q1 25 (Revenue/ EPS)
+0.02%
/-18.63%
Organon & Co. earnings per share and revenue
On Feb 12, 2026, OGN reported earnings of 0.63 USD per share (EPS) for Q4 25, missing the estimate of 0.73 USD, resulting in a -14.22% surprise. Revenue reached 1.51 billion, compared to an expected 1.55 billion, with a -3.06% difference. The market reacted with a -8.19% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.83 USD, with revenue projected to reach 1.51 billion USD, implying an increase of 31.75% EPS, and increase of 0.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were Organon & Co.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Organon & Co. reported EPS of $0.63, missing estimates by -14.22%, and revenue of $1.51B, -3.06% below expectations.
How did the market react to Organon & Co.'s Q4 2025 earnings?
The stock price moved down -8.19%, changed from $7.69 before the earnings release to $7.06 the day after.
When is Organon & Co. expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for Organon & Co.'s next earnings report?
Based on 4
analysts, Organon & Co. is expected to report EPS of $0.83 and revenue of $1.51B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement